SNvia
SNVIA is a global leader in transdermal drug delivery and diagnosis, specializing in embeddable microneedle and therapeutic polymer technology. As a subsidiary of Pusan National University, SNVIA is committed to developing innovative medical products that improve patient lives through advanced biomaterial technology.
Industries
Nr. of Employees
small (1-50)
SNvia
#405, Pnuavec, 50 Beongil 68,, Busandaehak-ro, Geumjeong-gu, Busan, Korea, 46241
Patents
Products
Research Grade Sodium Hyaluronate (HA-130K)
Powdered sodium hyaluronate for research use, molecular weight 100–130 kDa, packaged in small lab-scale quantities with QC documentation.
HAMA (Methacrylated Hyaluronic Acid, HAMA-100K)
Lyophilized methacrylated hyaluronic acid for research, high degree of substitution enabling rapid photo-crosslinking for tissue engineering and bioprinting applications.
Research Grade Sodium Hyaluronate (HA-130K)
Powdered sodium hyaluronate for research use, molecular weight 100–130 kDa, packaged in small lab-scale quantities with QC documentation.
HAMA (Methacrylated Hyaluronic Acid, HAMA-100K)
Lyophilized methacrylated hyaluronic acid for research, high degree of substitution enabling rapid photo-crosslinking for tissue engineering and bioprinting applications.
Services
Commercial sale of research-grade sodium hyaluronate in defined molecular-weight grades (e.g., 100–130 kDa) with per-batch GPC data, MSDS and COA.
Provision of HAMA (high degree of substitution) lyophilized powder for research uses including tissue engineering and 3D bioprinting; product specified for purity, DS and low endotoxin.
Manufacture of microneedle patches and development of microneedle fabrication processes including micro-dispensing and embedding technologies; production in qualified manufacturing facilities.
Co-development, licensing-out and partnership arrangements for platform technologies and product candidates, including support for SIT/IIT and partnering on clinical development.
Commercial sale of research-grade sodium hyaluronate in defined molecular-weight grades (e.g., 100–130 kDa) with per-batch GPC data, MSDS and COA.
Provision of HAMA (high degree of substitution) lyophilized powder for research uses including tissue engineering and 3D bioprinting; product specified for purity, DS and low endotoxin.
Manufacture of microneedle patches and development of microneedle fabrication processes including micro-dispensing and embedding technologies; production in qualified manufacturing facilities.
Co-development, licensing-out and partnership arrangements for platform technologies and product candidates, including support for SIT/IIT and partnering on clinical development.
Expertise Areas
- Transdermal drug delivery
- Microneedle platform development
- Therapeutic polymer development (hyaluronic acid derivatives)
- Photocurable hydrogel sealants
Key Technologies
- Embeddable and swellable microneedle patches
- Controlled-release microneedle drug delivery
- Grooved and shear-actuated microneedles
- Low-temperature micro-dispensing onto microneedles
News & Updates
A study on the degradation pattern of hyaluronic acid-based biodegradable and photocurable sealants in a rat craniectomy model.
Research on microneedle-mediated delivery of BCG vaccines for tuberculosis.
Study on hyaluronic acid-based wound dressings that prevent re-injury and promote healing.
Research on light-responsive hydrogel sealants for rapid wound closure.
Development of 3D bioprinted artificial cornea using visible light-crosslinkable bioinks.
A study on the degradation pattern of hyaluronic acid-based biodegradable and photocurable sealants in a rat craniectomy model.
Research on microneedle-mediated delivery of BCG vaccines for tuberculosis.
Study on hyaluronic acid-based wound dressings that prevent re-injury and promote healing.
Research on light-responsive hydrogel sealants for rapid wound closure.
Development of 3D bioprinted artificial cornea using visible light-crosslinkable bioinks.